The University of Michigan has developed a groundbreaking gastrointestinal device to help diagnose and predict treatment outcomes for chronic constipation. FDA-approved in 2024, the device offers a more efficient solution for primary care doctors, reducing unnecessary referrals and costs. The project was made possible through the MTRAC Life Sciences Innovation Hub, which played a key role in turning this breakthrough concept into a market-ready solution—discover how this innovative approach is reshaping healthcare.
We use cookies to ensure you get the best experience on our website. By using this site, you accept our use of cookies.